Detalhe da pesquisa
1.
Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
World J Surg Oncol
; 19(1): 311, 2021 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686186
2.
PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives.
Biomed Pharmacother
; 173: 116398, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458011
3.
Elevated Neutrophil-to-Lymphocyte Ratio Is Associated With Poor Outcomes for Melanoma Patients Treated With PD-1 Inhibitor or Chemotherapy in a Chinese Population.
Front Oncol
; 10: 1752, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33042821
4.
A study of the clinical characteristics and prognosis of advanced mucosal and cutaneous melanoma in a Chinese population.
Immunotherapy
; 11(2): 91-99, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30511592
5.
Elevated platelet-to-lymphocyte corresponds with poor outcome in patients with advanced cancer receiving anti-PD-1 therapy.
Int Immunopharmacol
; 74: 105707, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272066
6.
Platelet-to-lymphocyte ratio in peripheral blood: A novel independent prognostic factor in patients with melanoma.
Int Immunopharmacol
; 56: 143-147, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29414644
7.
Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer.
Onco Targets Ther
; 11: 6091-6100, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30275713
8.
Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review.
Onco Targets Ther
; 10: 4687-4690, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29026316
9.
Autologous cytokine-induced killer cell immunotherapy may improve overall survival in advanced malignant melanoma patients.
Immunotherapy
; 9(14): 1165-1174, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29067881